Athanasiadis P, Ravikumar B, Elliott RJR, Dawson JC, Carragher NO, Clemons PA, Johanssen T, Ebner D, Aittokallio T(2023) Chemogenomic library design strategies for precision oncology, applied to phenotypic profiling of glioblastoma patient cells iScience, 26(7), 107209 DOI 10.1016/j.isci.2023.107209, PubMed 37485377
Denisova OV, Merisaari J, Huhtaniemi R, Qiao X, Yetukuri L, Jumppanen M, Kaur A, Pääkkönen M, von Schantz-Fant С, Ohlmeyer M, Wennerberg K, Kauko O, Koch R, Aittokallio T, Taipale M, Westermarck J(2023) PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells Mol Oncol, 17(9), 1803-1820 DOI 10.1002/1878-0261.13488, PubMed 37458534
Wang MM, Coupland SE, Aittokallio T, Figueiredo CR(2023) Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities Br J Cancer(in press) DOI 10.1038/s41416-023-02361-4, PubMed 37454231